These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 4119418)

  • 1. Graft-versus-host disease and toxic epidermal necrolysis.
    Krueger GR
    Lancet; 1973 Feb; 1(7797):268-9. PubMed ID: 4119418
    [No Abstract]   [Full Text] [Related]  

  • 2. Graft-versus-host reaction and toxic epidermal necrolysis.
    Peck GL; Elias PM; Graw RG
    Lancet; 1972 Nov; 2(7787):1151-3. PubMed ID: 4117232
    [No Abstract]   [Full Text] [Related]  

  • 3. Toxic epidermal necrolysis after bone marrow transplantation: study of nine cases.
    Villada G; Roujeau JC; Cordonnier C; Bagot M; Kuentz M; Wechsler J; Vernant JP
    J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):870-5. PubMed ID: 2254472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis possibly linked to hyperacute graft-versus-host disease after allogeneic bone marrow transplantation.
    Takeda H; Mitsuhashi Y; Kondo S; Kato Y; Tajima K
    J Dermatol; 1997 Oct; 24(10):635-41. PubMed ID: 9375462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological differential diagnosis of drug-induced toxic epidermal necrolysis (Lyell's syndrome) and acute graft-versus-host reaction.
    Paquet P; Arrese JE; Beguin Y; Piérard GE
    Curr Top Pathol; 2001; 94():49-63. PubMed ID: 11443887
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic epidermal necrolysis.
    Ammann AJ; Tooley WH; Hong R
    Lancet; 1972 Sep; 2(7775):484-5. PubMed ID: 4115367
    [No Abstract]   [Full Text] [Related]  

  • 7. Toxic Epidermal Necrolysis in Recessive Dystrophic Epidermolysis Bullosa following Bone Marrow Transplantation.
    Boull CL; Hylwa SA; Sajic D; Wagner JE; Tolar J; Hook KP
    J Pediatr; 2016 Jun; 173():242-4. PubMed ID: 26976809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic epidermal necrolysis from graft-vs-host disease. Occurrence in a patient with thymic hypoplasia.
    McCarty JR; Raimer SS; Jarratt M
    Am J Dis Child; 1978 Mar; 132(3):282-4. PubMed ID: 24335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced toxic epidermal necrolysis.
    Heng MC
    Br J Dermatol; 1985 Nov; 113(5):597-600. PubMed ID: 4063192
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clues to pathogenesis of toxic epidermal necrolysis.
    Merot Y; Saurat JH
    Int J Dermatol; 1985 Apr; 24(3):165-8. PubMed ID: 3888879
    [No Abstract]   [Full Text] [Related]  

  • 12. Toxic epidermal necrolysis in a patient with graft-vs-host reaction.
    Peck GL; Herzig GP; Elias PM
    Arch Dermatol; 1972 Apr; 105(4):561-9. PubMed ID: 4401561
    [No Abstract]   [Full Text] [Related]  

  • 13. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 14. Cellular factors. Immunologic tolerance: irradiation and bone marrow transplantation in induction of canine allogeneic unresponsiveness.
    Rapaport FT; Bachvaroff RJ; Watanabe K; Hirasawa H; Cannon FD; Mollen N; Blumenstock DA; Ayvazian JH; Ferrebee JW
    Transplant Proc; 1977 Mar; 9(1):891-4. PubMed ID: 17203
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of genetic resistance and silica particles on survival after bone marrow transplantation.
    Vriesendorp HM; Löwenberg B; Visser TP; Knaan S; van Bekkum DW
    Transplant Proc; 1976 Sep; 8(3):483-9. PubMed ID: 10654
    [No Abstract]   [Full Text] [Related]  

  • 16. Extensive toxic epidermal necrolysis versus acute graft versus host disease after allogenic hematopoietic stem-cell transplantation: challenges in diagnosis and management.
    Macedo FI; Faris J; Lum LG; Gabali A; Uberti JP; Ratanatharathorn V; White MT
    J Burn Care Res; 2014; 35(6):e431-5. PubMed ID: 24476990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Graft-versus-host reaction, allogen diseases, and lymphoma].
    Grundmann E; Hobik HP
    Beitr Pathol; 1973 Dec; 150(4):323-9. PubMed ID: 4150407
    [No Abstract]   [Full Text] [Related]  

  • 18. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
    East-Innis AD; Thompson DS
    West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on the mechanism of stable graft-host tolerance in canine and human radiation chimeras.
    Storb R; Tsoi MS; Weiden PL; Graham TC; Thomas ED
    Transplant Proc; 1976 Dec; 8(4):561-4. PubMed ID: 11587
    [No Abstract]   [Full Text] [Related]  

  • 20. Adaptation of albumin density gradient centrifugation to human bone marrow fractionation.
    Dicke KA; Lina PH; van Bekkum DW
    Rev Eur Etud Clin Biol; 1970 Mar; 15(3):305-9. PubMed ID: 4392839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.